Vaxcyte, Inc. (PCVX) Tops Q3 EPS by 27c

Vaxcyte, Inc. (NASDAQ: PCVX) reported Q3 EPS of ($0.83), $0.27 better than the analyst estimate of ($1.10).

For earnings history and earnings-related data on Vaxcyte, Inc. (PCVX) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Flexsteel (FLXS) Tops Q4 EPS by 24c, Beats on Revenue; Offers Q1 Revenue Guidance
• iMetal Resources closes $3M private placement with McFarlane Lake